Reports >
Life Sciences
>
Carrier Screening Market Report
Carrier Screening Market Report
First published: 20 October 2024 | Last updated: 28 May 2026 | Report Code: carrier-screening
Carrier Screening Market — USD $1.5 Billion in 2023, Growing to USD 2.78null by 2033 at 6.2% CAGR
This comprehensive report covers the Carrier Screening market, detailing current trends, market size, growth forecasts, and regional analysis from 2023 to 2033. Insights include key segments, technological advancements, and competitive landscape assessments.
Key Takeaways
- Market expands from $1.50 Billion in 2023 to $2.78 Billion in 2033, reflecting a 6.2% CAGR over 2023 to 2033.
- North America is identified as the largest region, increasing from $0.5 Billion in 2023 to $0.93 Billion in 2033.
- North America is largest regional market; Latin America is regional market region based on implied CAGR across 2023 to 2033.
- Europe and Asia Pacific show notable increases—Europe from $0.44 Billion to $0.81 Billion, Asia Pacific from $0.31 Billion to $0.58 Billion.
- Leading companies include Invitae Corporation, Myriad Genetics, Inc., GeneDx, and Fulgent Genetics, reflecting active vendor participation.
Carrier Screening Market Report — Executive Summary
Regional analysis shows North America as largest market and Latin America as fastest-growing region by implied CAGR. The Carrier Screening Market Report outlines market size, regional performance, and major forces shaping adoption between 2023 and 2033. Market value is projected to grow from $1.50 Billion in 2023 to $2.78 Billion in 2033 at a 6.2% CAGR. Drivers include rising awareness of genetic disorders, technological advances such as next-generation sequencing, and broader integration into reproductive health services. Regional patterns show North America with the highest regional value and Latin America with the strongest implied growth rate. The report covers segmentation by service, technology, sample type, and end user, and profiles key companies including Invitae Corporation, Myriad Genetics, Inc., GeneDx, and Fulgent Genetics. Methodology combines primary interviews, secondary materials, and internal validation to ensure data consistency and trend interpretation.
Key Growth Drivers
- Increased public awareness of hereditary conditions driving demand for preconception and prenatal screening services.
- Advancements in sequencing and molecular techniques that enhance test accuracy and broaden panels.
- Integration of carrier screening into reproductive and personalized medicine pathways, expanding clinical use cases.
- Rising healthcare expenditure and regulatory frameworks improving access and standardization of testing.
- Greater provider adoption across hospitals, clinics, and laboratories facilitating higher testing volumes.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $1.50 Billion |
| CAGR (2023-2033) | 6.2% |
| 2033 Market Size | $2.78 Billion |
| Top Companies | Invitae Corporation, Myriad Genetics, Inc., GeneDx, Fulgent Genetics |
| Published Date | 20 October 2024 |
| Last Modified Date | 28 May 2026 |
Carrier Screening Market Overview
Customize Carrier Screening Market Report market research report
- ✔ Get in-depth analysis of Carrier Screening market size, growth, and forecasts.
- ✔ Understand Carrier Screening's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Carrier Screening
What is the Market Size & CAGR of Carrier Screening Market Report market in 2023?
Carrier Screening Industry Analysis
Carrier Screening Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Carrier Screening Market Report Market Analysis Report by Region
Europe Carrier Screening Market Report:
Europe grows from $0.44 Billion in 2023 to $0.81 Billion in 2033. Growth is influenced by expanding clinical guidelines, increasing public awareness of genetic conditions, and adoption across clinical laboratories and reproductive health services.Asia Pacific Carrier Screening Market Report:
Asia Pacific grows from $0.31 Billion in 2023 to $0.58 Billion in 2033. Momentum stems from rising healthcare investment, expanding testing availability, and greater incorporation of carrier screening into prenatal care pathways.North America Carrier Screening Market Report:
North America is largest regional market, rising from $0.5 Billion in 2023 to $0.93 Billion in 2033. Regional strength is supported by established diagnostic infrastructure, advanced sequencing adoption, and broad clinical integration in hospitals and laboratories.South America Carrier Screening Market Report:
Latin America is fastest-growing region by implied CAGR, increasing from $0.12 Billion in 2023 to $0.23 Billion in 2033. 12 Billion in 2023 to $0.23 Billion in 2033 and is noted as the regional growth market with an implied 6.72% CAGR. Increased market activity reflects growing awareness, expanding laboratory capabilities, and improving access to genetic services.Middle East & Africa Carrier Screening Market Report:
Middle East and Africa grows from $0.12 Billion in 2023 to $0.22 Billion in 2033. Regional expansion is supported by gradual increases in healthcare spending, improved diagnostic services, and growing attention to reproductive health testing.Tell us your focus area and get a customized research report.
Research Methodology
Carrier Screening Market Analysis By Service
The Carrier Screening market based on services includes Testing Services, Consulting Services, and Partner Services. Testing Services dominate the market, valued at $0.96 billion in 2023 and expected to reach $1.78 billion by 2033, capturing 63.99% market share. Consulting Services are projected to grow from $0.42 billion to $0.78 billion, holding 28.09% market share as healthcare providers increasingly offer genetic counseling.
Carrier Screening Market Analysis By Technology
Carrier Screening utilizes various technologies, including Molecular Techniques, Biochemical Methods, and Cytogenetic Techniques. Molecular Techniques lead the market with a size of $0.96 billion in 2023 and a forecasted growth to $1.78 billion by 2033, capturing a 63.99% share. Biochemical Methods and Cytogenetic Techniques follow, enhancing capabilities in screening and diagnosis.
Carrier Screening Market Analysis By End User
The end-user segmentation includes Hospitals, Clinics, Laboratories, Pharmaceutical Companies, and Other End-Users. Hospitals account for a significant share, valued at $0.65 billion in 2023, set to reach $1.20 billion by 2033. Clinics and laboratories are notable contributors, improving carrier screening accessibility and diagnostic precision.
Carrier Screening Market Analysis By Sample Type
Carrier Screening utilizes various sample types including Blood Samples, Saliva Samples, and Tissues. Blood Samples dominate the segment, valued at $0.96 billion in 2023, with expectations to reach $1.78 billion by 2033, holding a 63.99% market share. Saliva Samples and Tissues are also emerging as viable options, broadening the accessibility of screening.
Carrier Screening Market Analysis By Region Specific Services
Region-specific services are crucial in driving the Carrier Screening market. North America showcases robust service offerings, while Europe emphasizes regulatory compliance and quality assurance in testing methodologies. Growing services in Asia Pacific and Latin America are expanding education and outreach efforts, essential for increasing carrier screening uptake.
Carrier Screening Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Carrier Screening Industry
Invitae Corporation:
A leader in genetic testing, Invitae Corporation offers a wide range of carrier screening tests to support informed reproductive decisions. Their technology integrates genomic data with high-quality clinical performance.Myriad Genetics, Inc.:
Myriad Genetics specializes in hereditary cancer tests and offers comprehensive carrier screening solutions focusing on women's health and reproductive health.GeneDx:
GeneDx provides advanced genetic testing services, including carrier screening for various conditions, emphasizing hereditary disorders and personalized medicine.Fulgent Genetics:
With a focus on diversity and comprehensive genomic testing services, Fulgent Genetics offers carrier screening solutions that cater to various clinical needs.We're grateful to work with incredible clients.
FAQs
What is the market size of the Carrier Screening Market Report in 2023?
The market size in 2023 is $1.50 Billion, as reported for the Carrier Screening Market Report. This figure serves as the baseline for the 2023 to 2033 forecast.
How big will the market be in 2033?
The projected market value for 2033 is $2.78 Billion for the Carrier Screening Market Report, based on the provided forecast covering 2023 to 2033.
What is CAGR for the forecast period?
The CAGR for the 2023 to 2033 forecast is 6.2%, reflecting the compounded annual growth rate used to move from $1.50 Billion to $2.78 Billion.
Which region is the fastest Growing in the Carrier Screening Market Report market?
Latin America is the fastest-growing region, projected to expand from $0.12 Billion in 2023 to $0.23 Billion in 2033, reflecting an implied 6.72% CAGR over the forecast period.
Which region is fastest Growing?
Latin America is identified as the regional market region, increasing from $0.12 Billion in 2023 to $0.23 Billion in 2033 at an implied 6.72% CAGR.
Who are the top companies in this market?
Top companies named include Invitae Corporation, Myriad Genetics, Inc., GeneDx, and Fulgent Genetics, representing active commercial participants in carrier screening services.
What are common sample types used?
Reported sample types include Blood Samples, Saliva Samples, and Tissues, which are routinely used across carrier screening workflows and laboratory processes.
Which technologies are highlighted in the segmentation?
Segmentation lists Molecular Techniques, Biochemical Methods, and Cytogenetic Techniques as the main technology categories used in carrier screening testing.